|
 |
pioglitazone HClThis page contains recent news articles, when available, and an overview of pioglitazone HCl but does not offer medical advice. You should contact your physician with regard to any health issues or concerns....during an investigation of a March 2008 complaint about metallic foreign material found in its pioglitazone HCl diabetes drug, the letter says. ... FDA news (subscription) Pfizer Expands Chinese Presence - Analyst Blog - Dec 24, 2009 Takeda Pharmaceuticals, under which Pfizer will co-promote Takeda's Actos (pioglitazone HCl) with Tianjin Takeda Pharmaceuticals in China. ... Benzinga Pfizer China signs co-promotion agreement with Tianjin Takeda for Actos(R ... - Dec 16, 2009 Under the terms of the agreement, Pfizer China with Tianjin Takeda Pharmaceuticals will co-promote Takeda's Actos(R) (Pioglitazone HCl) in China. ... Trading Markets (press release) Takeda and Pfizer Team to Promote Takeda's Actos for the Treatment of Type 2 ... - Dec 20, 2009 ...entered into an agreement under which Pfizer in China will co-promote Takeda's Actos (pioglitazone HCl) with Tianjin Takeda Pharmaceuticals in China. ... Trading Markets (press release) PicksThatMove: www.PicksThatMove.com: "Picks that move" Alerts, December 15 ... - Dec 15, 2009 In a press release out on December 15, Takeda and Pfizer to Co-Promote Takeda's Actos(R) (Pioglitazone HCl) for the Treatment of Type 2 Diabetes in China ... TMC Net The Week in Review: Medical Device and Big Pharma Milestones - Dec 20, 2009 Actos® (pioglitazone HCl), an oral treatment for diabetes 2, produces over $4 billion of annual revenues for Takeda worldwide. ... Emerginvest ACTOplus met(TM) (pioglitazone HCl and metformin HCl) Now Available … - Nov 1, 2005 LINCOLNSHIRE, Ill., Nov. 1 /PRNewswire/ -- Takeda Pharmaceuticals North America, Inc. today announced that ACTOplus met(TM) (pioglitazone HCl and metformin ... Free with registration - PR Newswire - AccessMyLibrary.com New Analyses Show ACTOS(R) (pioglitazone HCl) Reduced Risk Of … - Sep 4, 2006 Results of new analyses found that ACTOS(R) (pioglitazone HCl), an oral antidiabetic medication, significantly reduced the risk of recurrent stroke in ... Medical News Today - Medical News Today (press release) … Announces Actoplus Met(TM)(pioglitazone HCl and metformin HCl) … - Aug 30, 2005 Tokyo, Aug 30, 2005 - (JCN Newswire) - Takeda Pharmaceutical Company Limited ("TAKEDA") announced today that its US R&D unit, Takeda Global Research ... japancorp.net New data show ACTOS (pioglitazone HCl) halted progression of … - Nov 13, 2006 Chicago, IL, November 13, 2006 -- Researchers today presented data showing that ACTOSо (pioglitazone HCl) halted the progression of atherosclerosis as ... PsychCentral.com ACTOS ® (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic … - Sep 19, 2007 AMSTERDAM, THE NETHERLANDS--(Marketwire - September 19, 2007) - Results presented today at the 43rd Annual Meeting of the European Association for the Study ... marketwire.com New Analyses Show ACTOS(R) (pioglitazone HCl) Reduced Risk of … - Sep 3, 2006 BARCELONA, Spain -- Results of new analyses found that ACTOS(R) (pioglitazone HCl), an oral antidiabetic medication, significantly reduced the risk of ... Free with registration - Business Wire - AccessMyLibrary.com ACTOS® (pioglitazone HCl) significantly improved components of … - Jun 29, 2005 Lincolnshire, IL, June 29, 2005 – A new study published in today's issue of Diabetes Care demonstrated that ACTOS improved components of diabetic ... eurekalert.org … Data Showed ACTOS ® (Pioglitazone HCl) Prevented Progression of … - Mar 31, 2008 CHICAGO, IL--(Marketwire - March 31, 2008) - New data from a clinical trial using intravascular ultrasound (IVUS) technology found that in patients living ... marketwire.com … Statement On ACTOS (pioglitazone HCl) Meta-Analysis Published In... - Sep 12, 2007 Takeda Pharmaceuticals Europe Ltd, is aware of the review of ACTOS® (pioglitazone HCl) data conducted by A. Michael Lincoff, MD, and colleagues at the ... Medical News Today - Medical News Today (press release) FDA Approves duetact(TM) (pioglitazone HCl and glimepiride) for the … - Jul 31, 2006 LINCOLNSHIRE, IL -- July 31, 2006 -- Takeda Pharmaceuticals North America, Inc. (TPNA) announced that the US Food and Drug Administration (FDA) has approved ... DG News ACTOS(R) (Pioglitazone HCl) Demonstrates Significant Improvements in ... - Sep 14, 2006 Several abstracts presented today at the 42nd Annual Meeting of the European Association for the Study of Diabetes (EASD) indicated that ACTOS(R) ... RedOrbit Diabetes 2, ACTOplus met(R) (pioglitazone HCl and metformin HCl) - Nov 6, 2005 Takeda Pharmaceuticals North America, Inc. today announced that ACTOplus metTM (pioglitazone HCl and metformin HCl) is now available by prescription in ... Medical News Today - Medical News Today (press release) … Data Showed ACTOS(R) (pioglitazone HCl) Prevented Progression of … - Mar 31, 2008 New Data Showed ACTOS(R) (pioglitazone HCl) Prevented Progression of Atherosclerotic Plaque Volume in Patients With Type 2 Diabetes. from PR Newswire Europe ... Pay-Per-View - PR Newswire Europe - HighBeam Research … 2 Diabetes Patients Taking ACTOS (Pioglitazone HCl) 22% Less... - Sep 18, 2007 An observational study based on a claims database of close to 30000 patients published in Pharmacoepidemiology and Drug Safety showed that ACTOS ... Medical News Today - Medical News Today (press release) … Data Showed ACTOS(R) (pioglitazone HCl) Prevented Progression of … - Mar 31, 2008 New Data Showed ACTOS(R) (pioglitazone HCl) Prevented Progression of Atherosclerotic Plaque Volume in Patients With Type 2 Diabetes. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research New Data Show ACTOS (pioglitazone HCl) Halted Progression Of … - Nov 18, 2006 On 13-Nov-2006 researchers presented data showing that ACTOS® (pioglitazone HCl) halted the progression of atherosclerosis as measured by carotid ... Medical News Today - Medical News Today (press release) Actos(R) (pioglitazone HCl) Reduces Heart Attacks, Strokes and Deaths... - Sep 13, 2005 Landmark data from the PROactive Study, presented at the 41st meeting of the European Association for the Study of Diabetes (EASD) in Athens demonstrated ... Medical News Today - Medical News Today (press release) … Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published... - Sep 11, 2007 Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research … study shows Takeda's Actos (pioglitazone HCl) reduced heart... - Sep 12, 2005 Landmark data from the PROactive study demonstrated that Actos (pioglitazone HCl) significantly reduced the combined risk of heart attacks, ... Pay-Per-View - Company Reports - Factiva, from Dow Jones … Release: ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of ... - Sep 19, 2007 ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research … Shows Takeda's ACTOS(R) (pioglitazone HCl) Reduces Heart Attacks, ... - Dec 9, 2005 Athens, Greece (ots/PRNewswire) - Landmark data from the PROactive Study, presented today at the 41st meeting of the European Association for the Study of ... presseportal.de duetact(TM) (pioglitazone HCl and glimepiride) Now Available in US … - Nov 7, 2006 DEERFIELD, Ill., Nov. 7 /PRNewswire/ -- Takeda Pharmaceuticals North America, Inc. announced that duetact(TM) (pioglitazone HCl and glimepiride), ... Free with registration - PR Newswire - AccessMyLibrary.com … : Takeda Revises ACTOS(R) (pioglitazone HCl) Prescribing Label. -... - Jun 6, 2007 Takeda Revises ACTOS(R) (pioglitazone HCl) Prescribing Label. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research ACTOS(R) (pioglitazone HCl) significantly improved components of … - Jun 30, 2005 A new study published in today's issue of Diabetes Care demonstrated that ACTOS improved components of diabetic dyslipidemia to a significantly greater ... Medical News Today - Medical News Today (press release) New Analyses Show (pioglitazone HCl) Reduced Risk of Secondary … - Sep 28, 2006 BARCELONA, Spain, Sept. 3 -- Results of new analyses found that ACTOS ® (pioglitazone HCl), an oral antidiabetic medication, significantly reduced the risk ... Medscape … the US for Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) for... - Sep 23, 2008 ...marketing approval of alogliptin (SYR-322) and ACTOS(R) (pioglitazone HCl) ("alogliptin/ACTOS") in a single tablet for the treatment of type 2 diabetes. ... International Business Times Press Release: ACTOplus met(TM) (pioglitazone HCl and metformin HCl) ... - Nov 1, 2005 ACTOplus met(TM) (pioglitazone HCl and metformin HCl) Now Available in US Pharmacies. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Pioglitazone HCl Plus Glimepiride Tablets (Duetact) for Type 2... - Aug 8, 2006 On July 28, the FDA approved pioglitazone HCl (Actos) plus glimepiride 30-mg/2-mg and 30-mg/4-mg tablets (Duetact, both made by Takeda Pharmaceuticals North ... Diabetes In Control Diabetes medication pioglitazone HCl may significantly improve … - May 9, 2005 Mainz, Germany, May 9, 2005 – Study results published in the May 17th issue of Circulation, the journal of the American Heart Association, found that the ... PsychCentral.com Press Release: duetact(TM) (pioglitazone HCl and glimepiride) Now … - Nov 7, 2006 ...duetact(TM) (pioglitazone HCl and glimepiride) Now Available in US Pharmacies. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Takeda Announces Marketing Authorisation for Tandemact(TM) ( … - Jan 17, 2007 The two approved strengths for Tandemact(TM) are pioglitazone HCl/glimepiride 30mg/4mg and 45mg/4mg. "We are very pleased with this approval of ... japancorp.net Actos (Pioglitazone HCl) Significantly Improves Components of... - Jul 5, 2005 Specifically, the results indicated that treatment with Actos lowered triglycerides (a type of lipid, or fat, found in food and the body), increased HDL-C ... Diabetes In Control Takeda Submits New Drug Application For Extended-release Type 2 … - Apr 6, 2006 ACTOS® (pioglitazone HCl) and ACTOplus met can cause fluid retention (swelling) that may lead to or worsen heart failure, so tell your doctor if you have a ... Medical News Today - Medical News Today (press release) Diabetes medication pioglitazone HCl may significantly improve … - May 10, 2005 Study results published in the May 17th issue of Circulation, the journal of the American Heart Association, found that the diabetes medication pioglitazone ... Medical News Today - Medical News Today (press release) Takeda submits new drug application for extended-release type 2 … - Apr 3, 2006 ACTOS® (pioglitazone HCl) and ACTOplus met can cause fluid retention (swelling) that may lead to or worsen heart failure, so tell your doctor if you have a ... eurekalert.org Add-on Effects of ACTOS(r) (pioglitazone HCl) - Jun 12, 2005 A new study has shown that people with type 2 diabetes on statin therapy for diabetic dyslipidemia who were switched to the oral anti-diabetic drug ACTOS ... Medical News Today - Medical News Today (press release) Press Release: ACTOS(R) (pioglitazone HCl) Demonstrates Significant … - Sep 14, 2006 ACTOS(R) (pioglitazone HCl) Demonstrates Significant Improvements in Cardiovascular Outcomes for High-Risk Patients with Type 2 Diabetes. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Press Release: ACTOplus met(TM) (pioglitazone HCl and metformin HCl) ... - Aug 29, 2005 ACTOplus met(TM) (pioglitazone HCl and metformin HCl) Approved by the FDA for Type 2 Diabetes. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Press Release: New Data Published in Circulation Showed an Increase … - Apr 15, 2008 New Data Published in Circulation Showed an Increase in HDL Cholesterol Levels with ACTOS(R) (pioglitazone HCl). from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research … : FDA Approves duetact(TM) (pioglitazone HCl and glimepiride) for... - Jul 31, 2006 FDA Approves duetact(TM) (pioglitazone HCl and glimepiride) for the Treatment of Type 2 Diabetes. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research Press Release: Data Presented at the American Heart Association … - Nov 6, 2007 ACTOS (pioglitazone HCl ... Takeda Pharmaceuticals North America, Inc., "By improving ... Article: ACTOS(R) (pioglitazone HCl) To Be Studied In New Trial . ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: ACTOS(R) (pioglitazone HCl) Significantly Improved … - Jun 29, 2005 ACTOS(R) (pioglitazone HCl) Significantly Improved Components of Diabetic Dyslipidemia. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research … US For Alogliptin (SYR-322) / ACTOS(R) (pioglitazone HCl) For The... - Sep 27, 2008 ...marketing approval of alogliptin (SYR-322) and ACTOS(R) (pioglitazone HCl) ("alogliptin/ACTOS") in a single tablet for the treatment of type 2 diabetes. ... Medical News Today - Medical News Today (press release) … : New Analyses Show ACTOS(R) (pioglitazone HCl) Reduced Risk of … - Sep 3, 2006 New Analyses Show ACTOS(R) (pioglitazone HCl) Reduced Risk of Secondary Stroke by Almost 50 Percent in High-Risk Type 2 Diabetes Patients. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Avandia, Other Diabetes Drugs to Add Boxed Warning on Heart Failure - Aug 16, 2007 ...and Takeda's Actos (pioglitazone HCl) and Duetact (pioglitazone HCl/glimepiride). These drugs are used in conjunction with diet and exercise to improve ... FDA news - FDA news (subscription) … : New Data Show ACTOS(R) (pioglitazone HCl) Halted Progression of … - Nov 13, 2006 New Data Show ACTOS(R) (pioglitazone HCl) Halted Progression of Atherosclerosis as Indicated by CIMT in Patients with Type 2 Diabetes. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research … Shows Takeda's ACTOS(R) (pioglitazone HCl) Reduces Heart Attacks, ... - Sep 12, 2005 PROactive Study Shows Takeda's ACTOS(R) (pioglitazone HCl) Reduces Heart Attacks, Strokes and Deaths. from PR Newswire Europe. Pay-Per-View - PR Newswire Europe - HighBeam Research … trial found that Actos (pioglitazone HCl) reduced the occurrence... - Jun 13, 2006 New analyses from the landmark PROactive Study found that Actos (pioglitazone HCl), an oral antidiabetic medication, significantly reduced the occurrence of ... Pay-Per-View - Company Reports - Factiva, from Dow Jones ACTOS(R) (pioglitazone HCl) To Be Studied In New Trial Investigating... - Jun 9, 2006 WASHINGTON, June 9 /PRNewswire-FirstCall/ -- Researchers today at the American Diabetes Association (ADA) 66th Annual Scientific Sessions presented data ... Free with registration - PR Newswire - AccessMyLibrary.com Takeda Pharmaceuticals submits NDA for a new oral diabetes medication - Jun 30, 2005 Takeda submitted a separate NDA for a combination of pioglitazone HCl and metformin HCl ... ACTOS(R) (pioglitazone HCl) directly targets insulin resistance, ... News-Medical.net Press Release: ACTOS(R) (pioglitazone HCl) To Be Studied In New Trial... - Jun 9, 2006 ACTOS(R) (pioglitazone HCl) To Be Studied In New Trial Investigating Its Effects On Atherosclerosis In Patients With Type 2 Diabetes. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Takeda Pharmaceuticals Submits New Drug Application For Combo of … - Jul 5, 2005 Takeda submitted a separate NDA for a combination of pioglitazone HCl and metformin HCl ... ACTOS(R) (pioglitazone HCl) directly targets insulin resistance, ... Diabetes In Control ACTOS(R) (pioglitazone HCl) To Be Studied In New Trial - Jun 13, 2006 Researchers at the American Diabetes Association (ADA) 66th Annual Scientific Sessions presented data showing the relationship between baseline ... Medical News Today - Medical News Today (press release) … Studies Examine the Effect of ACTOS(R) (pioglitazone HCl) on In... - Mar 7, 2005 WHAT: New studies presented this week, which look at the effects of ACTOS(R) (pioglitazone HCl) on in-stent restenosis, add to the growing body of ... $4.95 - PR Newswire - ECNext … Add-on Effects of ACTOS(R) (pioglitazone HCl) for Patients with... - Jun 11, 2005 ACTOS(R) (pioglitazone HCl) is a registered trademark of Takeda Pharmaceutical Company Limited and used under license by Takeda Pharmaceuticals North ... $4.95 - PR Newswire - ECNext FDA tentative generics approvals--2005.(Special Report)(Illustration) - Feb 27, 2006 107 mg 3/3/2005 and 160 mg Topiramate capsules, 15 mg and 25 3/9/2005 mg Terbinafine HCl tablets, 250 mg 3/10/2005 (base) Pioglitazone HCl tablets, ... Free with registration - Chain Drug Review - AccessMyLibrary.com OnMedica - News: TGRD Europe has been granted a marketing … - Aug 7, 2006 ...authorisation for Competact™, a fixed combination tablet of Actos ® (pioglitazone HCl) 15 mg and metformin HCl 850 mg from the European Commission. ... OnMedica Press Release: Takeda Submits New Drug Application for Extended- … - Apr 3, 2006 Article: FDA Approves ACTOplus met(R) XR (pioglitazone HCl ... PR Newswire; May 13, ... New data for ACTOplus met® (pioglitazone HCl and metformin ... 25mg. ... Pay-Per-View - PR Newswire - HighBeam Research New data shows ACTOS® reduced heart attacks by 28 percent in people … - Nov 16, 2005 ACTOS® (pioglitazone HCl) is a registered trademark of Takeda Pharmaceutical Company Limited and used under license by Takeda Pharmaceuticals North America, ... eurekalert.org Press Release: Takeda Submits a New Drug Application in the US for … - Sep 24, 2008 ...and ACTOS(R) (pioglitazone HCl) ("alogliptin/ACTOS") in a single tablet for ... 2 diabetes who are already treated with Actos (pioglitazone HCl tablets, ... Pay-Per-View - PR Newswire - HighBeam Research Takeda Responds to the FDA Advisory Committee Recommendation. - Jul 30, 2007 ACTOS([R]) (pioglitazone HCl) is a registered trademark of Takeda Pharmaceutical Company Limited and used under license by Takeda Pharmaceuticals North ... Free with registration - Business Wire - AccessMyLibrary.com Article: PPD Confirms Takeda's NDA Submission of Alogliptin and ACTOS... - Sep 27, 2008 Drug Administration for marketing approval of alogliptin (SYR-322) and ACTOS (pioglitazone HCl) in a single tablet for the treatment of type 2 diabetes. ... Pay-Per-View - Wireless News - HighBeam Research FDA tentative generics approvals--2005.(Special Report)(Illustration)... - Feb 27, 2006 107 mg3/3/2005 and 160 mg Topiramate capsules, 15 mg and 25 3/9/2005 mg Terbinafine HCl tablets, 250 mg 3/10/2005 (base) Pioglitazone HCl tablets, ... Pay-Per-View - Chain Drug Review - HighBeam Research Press Release: First Global Guidelines Endorse metformin ( … - Oct 3, 2005 ACTOplus met(R) (pioglitazone HCl and metformin HCl) as an adjunct to diet and ... Article: New Study Indicates Pioglitazone HCl/Metformin Combination ... ... Pay-Per-View - PR Newswire - HighBeam Research Eisai Corporation of North America.(MANUFACTURERS) | Article from … - Sep 1, 2008 Takeda Pharmaceuticals North America said the FDA has approved its application for Duetact (pioglitazone HCl and glimepiride), for the treatment of type 2 ... Pay-Per-View - Medical Marketing & Media - HighBeam Research ACTOS Not Associated With Increased Risk Of Heart Attack, Stroke, Or ... - Sep 14, 2007 ACTOS® (pioglitazone HCl) is a registered trademark of Takeda Pharmaceutical Company Limited and used under license by Takeda Pharmaceuticals North America, ... Medical News Today - Medical News Today (press release) Press Release: Takeda Submits New Drug Application for Combination … - Jun 30, 2005 Takeda submitted a separate NDA for a combination of pioglitazone HCl and metformin HCl ... ACTOS(R) (pioglitazone HCl) directly targets insulin resistance, ... Pay-Per-View - PR Newswire - HighBeam Research Takeda submits new drug application for combination type 2 diabetes … - Jun 29, 2005 Takeda submitted a separate NDA for a combination of pioglitazone HCl and metformin HCl ... ACTOSÆ (pioglitazone HCl) directly targets insulin resistance, ... PsychCentral.com … the Landmark PROactive Trial Found That ACTOS(R) (pioglitazone... - Jun 12, 2006 Article: ACTOS(R) (pioglitazone HCl) Demonstrates Significant ... PR Newswire; September 14, 2006 ; 700+ words ... ... presented at EASD showed that ACTOS ... Pay-Per-View - PR Newswire - HighBeam Research International Approvals: Januvia, Competact, Gardasil - Aug 14, 2006 On August 3, the European Commission approved pioglitazone HCl ( Actos) plus metformin HCl 15-mg/850-mg tablets ( Competact, made by Takeda Pharmaceutical ... Medscape FDA Approvals: Fluarix, Increlex, and ACTOplus met - Sep 1, 2005 29, the FDA approved pioglitazone HCl plus metformin HCl tablets (ACTOplus met, made by Takeda Pharmaceuticals North America, Inc.) for use as an adjunct to ... Medscape Article: Muraglitazar: new dual-action drug for diabetes. - Internal ... - Aug 15, 2005 Article: Study Findings Show Pioglitazone HCl Improves Glucose ... ... 5 mg, 15 mg, 30 mg or 45 mg of pioglitazone HCl once daily for 26 weeks ... from ... Pay-Per-View - Internal Medicine News - HighBeam Research Article: Centrix Pharmaceutical.(MANUFACTURERS) - Medical Marketing … - Aug 1, 2007 Takeda Pharmaceuticals North America said the FDA has approved its application for Duetact (pioglitazone HCl and glimepiride), for the treatment of type 2 ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Article: New diabetes drug class treats glucose and lipids.(News) -... - Aug 15, 2005 Article: Study Findings Show Pioglitazone HCl Improves Glucose ... ... 5 mg, 15 mg, 30 mg or 45 mg of pioglitazone HCl once daily for 26 weeks ... from ... Pay-Per-View - Family Practice News - HighBeam Research Article: Takeda Pharmaceuticals.(NEWS) - Medical Marketing & Media | ... - Sep 1, 2007 Takeda Pharmaceuticals North America said the FDA has approved its application for Duetact (pioglitazone HCl and glimepiride), for the treatment of type 2 ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Press Release: The Lancet Publishes Groundbreaking Proactive Study … - Oct 6, 2005 Takeda's ACTOS(R) (pioglitazone HCl) on Top of Standard Treatment Demonstrates ... Article: New Analyses Show ACTOS(R) (pioglitazone HCl) Reduced Risk ... ... Pay-Per-View - PR Newswire Europe - HighBeam Research Press Release: Takeda Wins Patent Infringement Litigation Against... - Feb 22, 2006 Takeda Wins Patent Infringement Litigation Against ANDA Filers for Generic ACTOS(R) (pioglitazone HCl). from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research … Litigation Against ANDA Filers for Generic ACTOS(R) (Pioglitazone... - Feb 22, 2006 ...rights have been successfully asserted against generic manufacturers seeking to challenge Takeda's patent rights to ACTOS(R) (pioglitazone HCl). ... RedOrbit The Lancet Publishes Groundbreaking Proactive Study Showing Type-2 … - Jul 10, 2005 A study published in The Lancet today shows that Takeda's ACTOS(R) (pioglitazone HCl), an oral glucose lowering medication, significantly reduces the ... presseportal.de Takeda Announces Status of Initial Marketing Authorisation Application... - Oct 23, 2006 The two recommended strengths for Tandemact are pioglitazone HCl/glimepiride; 30mg/4mg and 45mg/4mg respectively. TGRD Europe submitted that application on ... japancorp.net ACTOS(R) reduces heart attacks by 28 percent in people with type 2 … - Nov 21, 2005 ACTOS(R) (pioglitazone HCl) is a registered trademark of Takeda Pharmaceutical Company Limited and used under license by Takeda Pharmaceuticals North ... Medical News Today - Medical News Today (press release) Stroke Reduced By Almost 50 Percent By ACTOS - Sep 9, 2006 Results of new analyses found that ACTOS® (pioglitazone HCl), an oral antidiabetic ... ACTOS® (pioglitazone HCl) is a registered trademark of Takeda ... Medical News Today - Medical News Today (press release) … Studies Examine the Effect of ACTOS(R) (pioglitazone HCl) on In... - Mar 7, 2005 Three New Studies Examine the Effect of ACTOS(R) (pioglitazone HCl) on In-Stent Restenosis in Patients With and Without Diabetes; Results Presented at the ... Pay-Per-View - PR Newswire - HighBeam Research Diabetes Therapy; Takeda submits new drug application for extended- … - Apr 26, 2006 ACTOplus met is an oral medication that combines ACTOS (pioglitazone HCl), which directly targets insulin resistance - a condition in which the body does ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Ipos.(Update) | Article from Medical Marketing & Media | HighBeam … - Aug 1, 2005 Takeda Pharmaceuticals North America said the FDA has approved its application for Duetact (pioglitazone HCl and glimepiride), for the treatment of type 2 ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Takeda Pharmaceuticals North America.(Pipeline) | Article from... - Sep 1, 2006 Duetact combines Actos (pioglitazone HCl) and glimepiride in a single pill. Read all of this article with a FREE trial. COPYRIGHT 2006 Haymarket Media, ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Ambien hit with reports of sleep-eating.(NEWS)(Brief article) |... - Apr 1, 2006 Takeda Pharmaceuticals North America said the FDA has approved its application for Duetact (pioglitazone HCl and glimepiride), for the treatment of type 2 ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Takeda Pharmaceuticals The FDA has approved Pfizer's cholesterol- … - Nov 1, 2005 Takeda Pharmaceuticals North America said the FDA has approved its application for Duetact (pioglitazone HCl and glimepiride), for the treatment of type 2 ... Pay-Per-View - Medical Marketing & Media - HighBeam Research Press Release: New Research Shows ACTOS(R) (pioglitazone HCI) is … - Sep 19, 2007 Article: PROactive Study Shows Takeda's ACTOS(R) (pioglitazone HCl) ... PR Newswire Europe; September 12, 2005 ; 700+ words ... ... including death, ... Pay-Per-View - PR Newswire Europe - HighBeam Research FDA Advisory Committees Recommend Keeping Avandia on Market - Aug 1, 2007 Last month, the FDA requested a black box warning for Avandia and diabetes drug Actos (pioglitazone HCl), citing the increased risk of congestive heart ... FDA news - FDA news (subscription) Takeda Announces Marketing Authorisation Granted for Competact(TM)( … - Aug 3, 2006 ...authorisation for Competact(TM), a fixed combination tablet of ACTOS(R)(pioglitazone HCl) 15mg and metformin HCl 850mg from the European Commission. ... japancorp.net EC approves Takeda's antidiabetic Competact.(European Commission)( … - Aug 14, 2006 ...its fixed-combination tablet of Actos (pioglitazone HCl) 15mg and 850mg of the commonly-prescribed blood glucose regulator metformin HCl. ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Lancet publishes proactive study: Diabetes treatment reduces risk of... - Oct 7, 2005 London, UK, October 7, 2005 – A study published in The Lancet today shows that Takeda's ACTOS® (pioglitazone HCl), an oral glucose lowering medication, ... eurekalert.org New Drug Application For Alogliptin (syr-322) In The US Submitted By ... - Jan 7, 2008 In 1999, Takeda launched ACTOS® (pioglitazone HCl) - an insulin sensitizer which today is available globally - followed in recent years by the introduction ... Medical News Today - Medical News Today (press release) Takeda's Tandemact approved by EMEA.(European Medicines Agency)( … - Jan 29, 2007 Japan-based Takeda Pharmaceutical says that it has been granted European marketing authorization for the diabetes treatment Tandemact (pioglitazone HCl ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Federal Register 2007 - 72 FR 30386 Draft Guidances for Industry … - May 31, 2007 Pioglitazone HCl Miglustat Mirtazapine Modafinil Moexipril HCl Montelukast Sodium Morphine Sulfate Mycophenolate Mofetil Mycophenolate Mofetil HCl N ... Pay-Per-View - Federal Register 2007 - Loislaw Type 2 Diabetes: Treatment and Prevention - Sep 18, 2006 In a second study, German researchers tested the diabetes drug pioglitazone HCl (ACTOS) on patients with the disease. It's been proven to help people ... Ivanhoe Broadcast News Takeda submits new drug application for alogliptin (syr-322) in the US - Jan 3, 2008 In 1999, Takeda launched ACTOS® (pioglitazone HCl) — an insulin sensitizer which today is available globally — followed in recent years by the introduction ... eurekalert.org Pioglitazone Linked to Fracture Risk in Women - Mar 9, 2007 Pioglitazone HCl is currently marketed as a single drug ( Actos ) and in combination with metformin HCl ( Acto plus met ) or glimepiride ( duet act, ... Medscape Square Pharma eyes 100% growth in 2006 - Jul 27, 2006 In June this year, the company introduced etoricoxib variants under the Tory brand name and drugs like pioglitazone HCL, amlodipine + benazepril HCL, ... pharmabiz.com |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |